My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Revista de la OFIL
On-line version ISSN 1699-714XPrint version ISSN 1131-9429
Abstract
DIAZ-GAGO, A; VELEZ-DIAZ-PALLARES, M; MIHAELA-PIRLITU, A and ALVAREZ-DIAZ, A. Heart disorders in the context of hydroxychloroquine treatment for SARS-Cov2: a case report. Rev. OFIL·ILAPHAR [online]. 2020, vol.30, n.4, pp.337-338. Epub May 25, 2021. ISSN 1699-714X. https://dx.doi.org/10.4321/s1699-714x2020000400013.
We present the clinical case of a healthcare professional who has suffered a probable adverse reaction by hydroxychloroquine in the targeted treatment for SARS-Cov2. The patient was treated with hydroxychloroquine, azithromycin, and cefditoren, and after completing the treatment, she had cardiovascular disorders such as heart failure and tachycardia. At present, the benefit-risk balance appears to be unfavorable to the use of hydroxychloroquine in the treatment of SARS-Cov2 disease.
Keywords : Hidroxicloroquine; adverse drug events; COVID-19.